165 related articles for article (PubMed ID: 23028987)
1. Expression of TIP-1 confers radioresistance of malignant glioma cells.
Han M; Wang H; Zhang HT; Han Z
PLoS One; 2012; 7(9):e45402. PubMed ID: 23028987
[TBL] [Abstract][Full Text] [Related]
2. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
[TBL] [Abstract][Full Text] [Related]
3. Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions.
Trog D; Moenkemann H; Breipohl W; Schueller H; Schild H; Golubnitschaja O
Amino Acids; 2007; 32(3):373-9. PubMed ID: 17077962
[TBL] [Abstract][Full Text] [Related]
4. RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest.
Saigusa K; Imoto I; Tanikawa C; Aoyagi M; Ohno K; Nakamura Y; Inazawa J
Oncogene; 2007 Feb; 26(8):1110-21. PubMed ID: 17146433
[TBL] [Abstract][Full Text] [Related]
5. A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2.
Wang J; He X; Luo Y; Yarbrough WG
Biochem J; 2006 Jan; 393(Pt 2):489-501. PubMed ID: 16173922
[TBL] [Abstract][Full Text] [Related]
6. Enhanced radiation-induced cytotoxic effect by 2-ME in glioma cells is mediated by induction of cell cycle arrest and DNA damage via activation of ATM pathways.
Zou H; Zhao S; Zhang J; Lv G; Zhang X; Yu H; Wang H; Wang L
Brain Res; 2007 Dec; 1185():231-8. PubMed ID: 17980860
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.
Ito H; Kanzawa T; Miyoshi T; Hirohata S; Kyo S; Iwamaru A; Aoki H; Kondo Y; Kondo S
Hum Gene Ther; 2005 Jun; 16(6):685-98. PubMed ID: 15960600
[TBL] [Abstract][Full Text] [Related]
8. Suppression of p53 activity by Siva1.
Du W; Jiang P; Li N; Mei Y; Wang X; Wen L; Yang X; Wu M
Cell Death Differ; 2009 Nov; 16(11):1493-504. PubMed ID: 19590512
[TBL] [Abstract][Full Text] [Related]
9. Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation.
Jowsey PA; Doherty AJ; Rouse J
J Biol Chem; 2004 Dec; 279(53):55562-9. PubMed ID: 15456759
[TBL] [Abstract][Full Text] [Related]
10. Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model.
Pei J; Park IH; Ryu HH; Li SY; Li CH; Lim SH; Wen M; Jang WY; Jung S
Radiat Oncol; 2015 Aug; 10():164. PubMed ID: 26245666
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
12. RAD18 mediates resistance to ionizing radiation in human glioma cells.
Xie C; Wang H; Cheng H; Li J; Wang Z; Yue W
Biochem Biophys Res Commun; 2014 Feb; 445(1):263-8. PubMed ID: 24518219
[TBL] [Abstract][Full Text] [Related]
13. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE.
Xu LM; Chen L; Li F; Zhang R; Li ZY; Chen FF; Jiang XD
J Exp Clin Cancer Res; 2016 Oct; 35(1):162. PubMed ID: 27733185
[TBL] [Abstract][Full Text] [Related]
15. High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53.
Iwadate Y; Mizoe J; Osaka Y; Yamaura A; Tsujii H
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):803-8. PubMed ID: 11395250
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
[TBL] [Abstract][Full Text] [Related]
17. Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.
Fedrigo CA; Grivicich I; Schunemann DP; Chemale IM; dos Santos D; Jacovas T; Boschetti PS; Jotz GP; Braga Filho A; da Rocha AB
Radiat Oncol; 2011 Nov; 6():156. PubMed ID: 22077956
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.
Tallen UG; Truss M; Kunitz F; Wellmann S; Unryn B; Sinn B; Lass U; Krabbe S; Holtkamp N; Hagemeier C; Wurm R; Henze G; Riabowol KT; von Deimling A
J Neurooncol; 2008 Jan; 86(1):23-30. PubMed ID: 17763999
[TBL] [Abstract][Full Text] [Related]
19. EZH2 Palmitoylation Mediated by ZDHHC5 in p53-Mutant Glioma Drives Malignant Development and Progression.
Chen X; Ma H; Wang Z; Zhang S; Yang H; Fang Z
Cancer Res; 2017 Sep; 77(18):4998-5010. PubMed ID: 28775165
[TBL] [Abstract][Full Text] [Related]
20. The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma.
Mehta S; Huillard E; Kesari S; Maire CL; Golebiowski D; Harrington EP; Alberta JA; Kane MF; Theisen M; Ligon KL; Rowitch DH; Stiles CD
Cancer Cell; 2011 Mar; 19(3):359-71. PubMed ID: 21397859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
